Cigna Group announced it will withdraw from the Affordable Care Act (ACA) individual insurance market after 2026, leaving approximately 369,000 members across 11 states needing to secure alternative coverage for 2027. The decision, disclosed alongside the company's first-quarter earnings report, adds to the challenges facing the Obamacare marketplace, which is already under pressure from rising costs and reduced federal subsidies.
Market Context and Timing
The exit comes as enhanced premium tax credits expired at the end of 2025, removing significant federal support and causing monthly premiums to climb for many ACA enrollees this year. According to KFF, 80% of returning marketplace shoppers saw increases in premiums, deductibles, or cost sharing for 2026, with 51% describing the jump as "a lot higher." Despite these headwinds, federal enrollment remains substantial at 23.1 million people for 2026 plans, though a shift toward leaner bronze plans suggests consumers are seeking to manage costs.
Industry-Wide Pullback
Cigna is not alone in stepping back from the ACA market. CVS Health's Aetna earlier announced it would stop selling ACA individual plans for 2026, impacting roughly 1 million members across 17 states. This marks the second time in a decade that Aetna has exited the marketplace. Brian Evanko, Cigna's president and COO, stated that there is no "clear path to scale this business" within Cigna's overall portfolio, though he emphasized that coverage and networks for 2026 will not be affected. Cigna plans to assist members during the 2027 open enrollment period, which begins November 1, 2026.
Financial Performance and Strategy
The retreat came as Cigna reported a stronger-than-expected first quarter. Revenue reached $68.5 billion, net income was $1.7 billion, and adjusted income from operations hit $2.1 billion, or $7.79 per share. The company raised its 2026 adjusted earnings forecast to at least $30.35 per share. Bernstein analyst Lance Wilkes described the quarter as "solid," citing disciplined healthcare pricing and better-than-anticipated pharmacy benefit management margins. Evanko, who will become CEO on July 1, is reshaping Cigna's portfolio, focusing on employer-sponsored insurance and its Evernorth health-services division, which includes pharmacy benefit management. The company is also evaluating options for its EviCore medical review business.
Implications for the ACA Market
Cigna's departure could exacerbate market instability. Wakely Consulting Group has projected a 17% to 26% decline in 2026 ACA enrollment from 2025, warning that healthier enrollees are more likely to leave, while sicker members remain. This adverse selection could tip the risk pool, making it even harder for remaining insurers to set premiums for 2027. Cigna currently offers individual and family plans in Arizona, Colorado, Florida, Georgia, Illinois, Indiana, Mississippi, North Carolina, Tennessee, Texas, and Virginia for 2026.
Market Reaction
Investors took the news in stride, with Cigna shares slipping less than 1% to $291.46 in New York. The modest reaction suggests the market views the ACA exit as a routine portfolio adjustment rather than a fundamental shift in Cigna's earnings story.
